Table of Contents
ISRN Neurology
Volume 2014, Article ID 579242, 6 pages
http://dx.doi.org/10.1155/2014/579242
Research Article

Small Fiber Neuropathy Associated with Hyperlipidemia: Utility of Cutaneous Silent Periods and Autonomic Tests

Ufuk University Medical School, Department of Neurology, Mevlana Bulvarı No. 86-88, Balgat, 06500 Ankara, Turkey

Received 12 January 2014; Accepted 9 February 2014; Published 19 March 2014

Academic Editors: T. Kato and Y. Sunada

Copyright © 2014 G. Morkavuk and A. Leventoglu. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Uncini, T. Kujirai, B. Gluck, and S. Pullman, “Silent period induced by cutaneous stimulation,” Electroencephalography and Clinical Neurophysiology, vol. 81, no. 5, pp. 344–352, 1991. View at Google Scholar · View at Scopus
  2. M. Serrao, L. Parisi, F. Pierelli, and P. Rossi, “Cutaneous afferents mediating the cutaneous silent period in the upper limbs: evidences for a role of low-threshold sensory fibres,” Clinical Neurophysiology, vol. 112, no. 11, pp. 2007–2014, 2001. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Inghilleri, G. Cruccu, M. Argenta, L. Polidori, and M. Manfredi, “Silent period in upper limb muscles after noxious cutaneous stimulation in man,” Electroencephalography and Clinical Neurophysiology, vol. 105, no. 2, pp. 109–115, 1997. View at Publisher · View at Google Scholar · View at Scopus
  4. W. J. Fessel, “Fat disorders and peripheral neuropathy,” Brain, vol. 94, no. 3, pp. 531–540, 1971. View at Publisher · View at Google Scholar · View at Scopus
  5. U. Sandbank and J. J. Bubis, “Hyperlipemic neuropathy: experimental study,” Brain, vol. 96, no. 2, pp. 355–358, 1973. View at Google Scholar · View at Scopus
  6. P. G. McMannis, A. J. Windebank, and M. Kızıltan, “Neuropathy associated with hyperlipidemia,” Neurology, vol. 44, pp. 2185–2186, 1994. View at Google Scholar
  7. H. S. Kassem, S. T. Azar, M. S. Zantout, and R. A. Sawaya, “Hypertriglyceridemia and peripheral neuropathy in neurologically asymptomatic patients,” Neuroendocrinology Letters, vol. 26, no. 6, pp. 775–779, 2005. View at Google Scholar · View at Scopus
  8. W. S. David, Z. Mahdavi, M. Nance, and M. Khan, “Hyperlipidemia and neuropathy,” Electromyography and Clinical Neurophysiology, vol. 39, no. 4, pp. 227–230, 1999. View at Google Scholar · View at Scopus
  9. E. L. Feldman, M. J. Stevens, P. K. Thomas, M. B. Brown, N. Canal, and D. A. Greene, “A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy,” Diabetes Care, vol. 17, no. 11, pp. 1281–1289, 1994. View at Google Scholar · View at Scopus
  10. E. J. Bastyr III, K. L. Price, and V. Bril, “Development and validity testing of the neuropathy total symptom score-6: questionnaire for the study of sensory symptoms of diabetic peripheral neuropathy,” Clinical Therapeutics, vol. 27, no. 8, pp. 1278–1294, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. I. Unal-Cevik, S. Sarioglu-Ay, and D. Evcik, “A comparison of the DN4 and LANSS questionnaires in the assessment of neuropathic pain: validity and reliability of the turkish version of DN4,” Journal of Pain, vol. 11, no. 11, pp. 1129–1135, 2010. View at Publisher · View at Google Scholar · View at Scopus
  12. S. J. Oh, “Nerve conduction techniques,” in Clinical Electromyography: Nerve Conduction Studies, pp. 37–52, Lippincott Williams Wilkins, 3rd edition, 2002. View at Google Scholar
  13. O. May and H. Arildsen, “Assessing cardiovascular autonomic neuropathy in diabetes mellitusHow many tests to use?” Journal of Diabetes and Its Complications, vol. 14, no. 1, pp. 7–12, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. S. J. Oh, “Special nerve conduction techniques,” in Clinical Electromyography: Nerve Conduction Studies, pp. 447–503, Lippincott Williams & Wilkins, 3rd edition, 2002. View at Google Scholar
  15. M. Kofler, “Functional organization of exteroceptive inhibition following nociceptive electrical fingertip stimulation in humans,” Clinical Neurophysiology, vol. 114, no. 6, pp. 973–980, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M. K. Floeter, “Cutaneous silent periods,” Muscle and Nerve, vol. 28, no. 4, pp. 391–401, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. G. Lauria, M. Morbin, R. Lombardi et al., “Axonal swellings predict the degeneration of epidermal nerve fibers in painful neuropathies,” Neurology, vol. 61, no. 5, pp. 631–636, 2003. View at Google Scholar · View at Scopus
  18. C. H. Gibbons, J. W. Griffin, M. Polydefkis et al., “The utility of skin biopsy for prediction of progression in suspected small fiber neuropathy,” Neurology, vol. 66, no. 2, pp. 256–258, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. D. N. Herrmann, M. L. Ferguson, V. Pannoni, R. L. Barbano, M. Stanton, and E. L. Logigian, “Plantar nerve AP and skin biopsy in sensory neuropathies with normal routine conduction studies,” Neurology, vol. 63, no. 5, pp. 879–885, 2004. View at Google Scholar · View at Scopus
  20. K. R. Sharma, D. Saadia, A. G. Facca, S. Resnick, and D. R. Ayyar, “Diagnostic role of deep tendon reflex latency measurement in small-fiber neuropathy,” Journal of the Peripheral Nervous System, vol. 12, no. 3, pp. 223–231, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. G. Devigili, V. Tugnoli, P. Penza et al., “The diagnostic criteria for small fibre neuropathy: from symptoms to neuropathology,” Brain, vol. 131, no. 7, pp. 1912–1925, 2008. View at Publisher · View at Google Scholar · View at Scopus
  22. B.-J. Kim, N.-H. Kim, S. G. Kim et al., “Utility of the cutaneous silent period in patients with diabetes mellitus,” Journal of the Neurological Sciences, vol. 293, no. 1-2, pp. 1–5, 2010. View at Publisher · View at Google Scholar · View at Scopus
  23. P. D. Aravindan and M. Lioyed, “Scalp pain and hyperlipidemia,” International Journal of Clinical Practice, vol. 54, pp. 478–490, 2000. View at Google Scholar
  24. T. D. Wiggin, K. A. Sullivan, R. Pop-Busui, A. Amato, A. A. F. Sima, and E. L. Feldman, “Elevated triglycerides correlate with progression of diabetic neuropathy,” Diabetes, vol. 58, no. 7, pp. 1634–1640, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. A. A. Leis, “Conduction abnormalities detected by silent period testing,” Electroencephalography and Clinical Neurophysiology, vol. 93, no. 6, pp. 444–449, 1994. View at Google Scholar · View at Scopus
  26. N. A. Syed, F. Sandbrink, C. A. Luciano et al., “Cutaneous silent periods in patients with Fabry disease,” Muscle Nerve, vol. 23, pp. 1179–1186, 2000. View at Google Scholar
  27. F. M. Corsi, S. Fausti, M. Serrao, C. Casali, L. Parisi, and G. Piazza, “Electromyographic mixed nerve and cutaneous silent period in evaluating the A-delta fibres in a patient with hereditary sensory-autonomic neuropathy,” Functional Neurology, vol. 17, no. 1, pp. 31–34, 2002. View at Google Scholar · View at Scopus
  28. M. Yaman, D. Uludüz, S. Yüksel, G. Pay, and M. E. Kiziltan, “The cutaneous silent period in diabetes mellitus,” Neuroscience Letters, vol. 419, pp. 258–262, 2007. View at Google Scholar
  29. M. R. Onal, U. H. Ulas, O. Oz et al., “Cutaneous silent period changes in Type 2 diabetes mellitus patients with small fiber neuropathy,” Clinical Neurophysiology, vol. 121, no. 5, pp. 714–718, 2010. View at Publisher · View at Google Scholar · View at Scopus